Abstract
Introduction: There is clinical evidence that the fresh blood viscosity is an important indicator in the development of vascular disorder and coagulation. However, existing clinical viscosity measurement techniques lack the ability to measure blood viscosity and replicate the in-vivo hemodynamics simultaneously.
Methods: Here, we fabricate a novel digital device, called Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV) which shows capacities in both viscosity measurement and coagulation monitoring.
Results: Based on the Hagen-Poiseuille equation, viscosity analysis can be faithfully performed by a video microscopy. Tesla-like channel ensured unidirectional liquid motion with stable pressure driven that was triggered by the interaction of Tesla valve structure and ultrasound waves. In few seconds the TUBPV can generate an accurate viscosity profile on clinic fresh blood samples from the flow time evaluation. Besides, Tesla-inspired microchannels can be used in the real-time coagulation monitoring.
Discussion: These results indicate that the TUBVP can serve as a point-of-care device in the ICU to evaluate the blood’s viscosity and the anticoagulation treatment.
Introduction
Hemodynamics constitutes the comprehensive investigation of fluid dynamics within the circulatory system (Jain et al., 2016; Zhang et al., 2022; Tyagi et al., 2022). The precise characterization of flow behaviors plays a pivotal role in the realms of diagnosing and treating conditions associated with the circulatory system (Ferro et al., 2004; Mandal, 2005; Foley et al., 2012; Chen et al., 2023). Viscosity is possibly the most important parameter to characterize the different phenomena observed in blood flow (Bodnár et al., 2011; Rubio et al., 2022; Jędrzejczak et al., 2023). Usually, the increase of blood viscosity is regarded as the risk for the abnormally elevated blood flow resistance, such as in chronic vascular disease, and endothelial dysfunction (Valeanu et al., 2021; Al-kuraishy et al., 2022; De Leonardis et al., 2022; Wen et al., 2022). Acute physical exercise even causes a 10% increase of blood viscosity (El-Sayed et al., 2005; Connes et al., 2012). Besides, acute assessment of coagulopathy is important for the clinical judgement of anticoagulation drug treatment in diseases like thrombosis or bleeding (Ganter and Hofer, 2008; Carroll et al., 2009; Munoz et al., 2009; Chen et al., 2022). However, current viscometers are limited in their singular focus on viscosity measurements and lack the ability to replicate the in vivo hemodynamics accurately (Saha et al., 2021; Fuiano et al., 2022; Yi et al., 2022). Thus, there is a critical need to develop new strategy that enables rapid measurements of blood viscosity and continuous monitoring the coagulopathy simultaneously.
Inspired by Tesla valves, invented by Nikola Tesla, here we design a blood plasma viscometer that can also monitor the coagulopathy. Tesla-inspired microchannels not only can be used as fluidic diodes that allow fluid to pass easily in forward direction while resist the fluid to flow in the reverse direction (Nguyen et al., 2021; Bohm et al., 2022; Li et al., 2023), also can be employed in designs for real-time flow monitoring (Groisman and Quake, 2004; Hong et al., 2004; Hossain et al., 2010; Zhang et al., 2016; Ting et al., 2019; Wang et al., 2022). With the constant pressure driven, the flow shows stable flowing velocity, underscoring its potential for deployment in capillary-type viscometer (Kang et al., 2019; Bhattad, 2023). In addition, the Tesla-like microchannel can mimic the physiological shear rates in blood flows, providing a more faithful platform for analyzing the coagulopathy. Notably, the conventional flow driver in microfluidic viscometers, typically a peristaltic pump, is both cost-intensive, and space-, blood-consuming, showing difficulty in the point-of-care testing (Leach et al., 2003; Xie et al., 2004; Collins et al., 2016; Davis et al., 2021). Thus, a miniaturized and user-friendly platform is supposed to be developed for the microfluidic pumping in the clinic.
Acoustic streaming implemented in microfluidics has triggered various applications, such as mixing, particle manipulation, droplet manipulation, and flow control (Ding et al., 2013; Guo et al., 2015a; Guo et al., 2015b; Guo et al., 2015c; Collins et al., 2017; Hu et al., 2020; Ao et al., 2022; Zhang et al., 2022; Durrer et al., 2022; Wu et al., 2022; Wu et al., 2023a; Wu et al., 2023b; Del Campo Fonseca et al., 2023; Xu et al., 2023). Among these applications, acoustic streaming-induced fluid pumping shows the excellent properties including miniaturization, contactless, precise, stability, and tunability, which has been integrated into the point-of-care usages (Du et al., 2009; Dentry et al., 2014; Huang et al., 2014; Wu et al., 2019; Cai et al., 2020). These features indicate the great potential of acoustic streaming-induced pumping integrated into the designated microchannel. Thus, the integration of acoustic streaming and the Tesla-like microchannel would result in a new blood viscometer that has real-time monitoring functions.
In this work, we establish a simple and reliable platform for measuring blood plasma viscosity and monitoring coagulopathy, as shown in Figure 1A. This platform consists of the Tesla valve-based microchannel and ultrasound wave generator. The mechanism of viscosity measurements is similar to that in the capillary-type viscometer. The flow is driven by the acoustic streaming from the ultrasound-structure interaction. Besides, the flow direction is regulated by the Tesla-like structure’s fluid diode. Further, we demonstrate that the viscometer capability based on the Tesla valves and ultrasound waves. Benefited from the controllability of the ultrasound waves, the flow behavior can be programmed and further used to mimic the coagulopathy. These results indicate that the significant potential in the point-of-care blood viscosity and coagulopathy management.
FIGURE 1
Results
Device design and working principle. The Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV) consists of a piezoelectric transducer and a channel with Tesla valve structures (Supplementary Figure S1), showing the stable, fast, disposable, small-volume, and precise measurement properties. This capillary-type viscometer supports visual measurements of liquids’ viscosity proportional to the flowing time under a constant distance, referring to the following Hagen-Poiseuille equation (Prusa, 2008):where is the liquid viscosity, is the channel radius, represents the pressure inside the channel, is the length from position A to B, means the liquid volume, and is the flowing time. Notably, the pressure is induced and well-controlled by the ultrasonic radiation, driving the liquid movement (Supplementary Movie S1). Combining with the regulation of Tesla valve conduit, the liquid driven by stable ultrasound waves showed the unidirectional and rapid flow motion. The Tesla valve conduit was fabricated by 3D printer and disposable with zero clean up, enabling to load liquid sample as low as 200 μL (Figure 1B). Benefitting from the ultrahigh speed imaging of the charge-coupled device (CCD), the flowing time can be precisely recorded, resulting in the high accuracy of viscosity measurements (Figure 1C). These features of the TUBPV indicate great potential in point-of-care blood testing.
Performance of the Tesla valve’s conduit. To access the regulation of the Tesla valve conduit on the liquid flows, we introduced liquids in the forward and reverse directions, respectively (Figures 2A,B). The relative streakline visualization reflected the effects of the conduit structures on flow acceleration and deceleration (Supplementary Movie S2 and Supplementary Movie S3). Using the same pressure as liquid propulsion, flow rates under two directions inside the conduit were significantly different (Figure 2C). The equivalent pressure values also indicated that the unique structures of Tesla valve have diodic behavior (Figure 2D). Besides, we quantified the hydrodynamic resistance versus input signal power for the forward and reverse flowing directions: is the pressure difference, is the volumetric flow rate. Figure 2E showed the larger resistance on the reverse flowing directions. These results indicate that the Tesla-like channel can convert high-frequency pulsatile flows into unidirectional flows that towards the forward direction.
FIGURE 2
Pumping behavior powered by ultrasonic-structure interactions. We next tested and validated the unidirectional pumping powered by the ultrasonic-structure interactions using theoretical and experimental approaches. Here, the piezoelectric transducer and Tesla valve conduit were deposited on the glass substrate. Applying electric signals on the transducer, high-frequency vibrations can be generated and induce the forward and reverse pulsatile flows inside the channel. Owing the fluidic diode property of Tesla valve, the liquid pressure in reverse direction is greatly larger than that in forward direction. Consequently, stable unidirectional flow can be generated in the ultrasonic-coupled structures (Figure 3A). Under the resonant frequency, we performed the numerical simulation that showed the piezoelectric transducer can drive one-way flow inside Tesla-like channel (Figures 3B–D). Flow details in basic unit of Tesla valve showed the fluidic diodic behavior (Supplementary Figure S2). To assess the unidirectional flow, we added polystyrene beads in the liquid and recorded their movements at different time points (Figure 3E). Further, the flow rate can be precisely controlled by the input signal power, ranging from tens to hundreds of micrometers per seconds (Figure 3F). In particular, the pumping performance was programmable and repeatable by using cyclic signal stimulus (Figure 3G and Supplementary Movie S4). Thus, the digital and controllable ultrasonic stimulus ensures the reliable and stable driving force to the one-way liquid movement.
FIGURE 3
Validation of the blood viscometer capacity. Having validated the pumping behavior in the Tesla-like channel under the steady ultrasonic driving force, we next calibrated and verified the capacity of this ultrasound waves-powered Tesla-like channel on liquid viscosity measurements. Based on the Hagen-Poiseuille Equation 1, liquid viscosity is proportional to the flowing time from position A to B, owing to other parameters can be regarded as the constant factor (Figures 4A,B). By applying an 8-w power of electric signal on the piezoelectric transducer, steady pressure can be obtained inside the Tesla-like channel (Figure 4C). We found that the temperature in the channel was independent from the ultrasonic radiation (Supplementary Figure S3). Besides, the shear rate remained constant due to the stable flow rate, as shown in Figure 4D, indicating the accuracy on measuring liquid viscosities. Benefitting from the reliable and stable pumping performance, the ultrasound waves-powered Tesla-like channel herein acted as a proof of concept for the liquid viscosity measurement.
FIGURE 4
The calibration and verification steps need to be carried out for transforming the ultrasound waves-powered Tesla-like channel into practical viscometer. We used glycerol solutions to calibrate the viscometer performance (Figures 4E,F). When viscosity values of glycerol solutions were plotted against their concentrations, we found that they followed a sigmoidal trend. Next, five standard glycerol solutions with viscosities at 0.95 cp, 1.90 cp, 3.80 cp, 7.60 cp, and 15.2 cp were prepared following the sigmoidal fit and added into the channel (Figure 4G). Based on the relative flowing time recording, we obtained the mathematical formulation of liquid viscosity and flowing time, as shown in Figure 4H. We then experimentally tested this model by investigating flowing times of twenty kinds of liquids (Figure 4I). All the liquids data were presented in Supplementary Table S1. We found that all the results were located in the 95% confidence band of the formulation. These results indicated that the ultrasound waves-powered Tesla-like channel can serve as practical viscometer with high stability and accuracy.
Rapid hemodynamic analysis in vitro. To test the practical performance of the Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV), we analyzed the hemodynamics including viscosity measurements of blood plasma samples and the blood coagulation monitoring. First, we measured the blood plasma viscosities by assessing the flowing time from position A to B in the empty channel (Figure 5A). Our TUBPV achieved the rapid measurement of viscosity within 10 s for each sample, avoiding the platelet aggregation. In particular, our TUBPV can distinguish the blood states in a precise manner. Figure 5B showed the accuracy of our TUBPV at 95.4% on the viscosity measurement compared with the clinical measured values. Besides, our TUBPV can monitor the coagulation status of patients in real time. Owing to the microscale and vascular-like channel, coagulation can form after long-time closed-loop flowing, as shown in Figure 5C. Collectively, our TUBPV provides a new type of viscometer that enables the precise measurement of blood plasma viscosity and the real-time monitoring of blood coagulation status simultaneously.
FIGURE 5
Discussion and conclusion
We have demonstrated a novel viscometer that offers the stable, fast, disposable, small-volume, and precise measurement of blood plasma’s viscosity, providing a point-of-care method for precisely monitoring blood hemodynamics. This viscometer exploits Tesla-like flow regulator, ultrasound-based liquid pumping, and on-chip miniaturization to achieve both real-time viscosity measurements and hemodynamic analysis in vitro. This viscometer can be adapted for viscosity analysis of a range of biological fluids with the rapid feature and clear clinical implications.
The performance and capability of this Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV) can be further improved and extended. The dimension of the Tesla-like channel could be optimized for obtaining an optimal ability in flow regulation, resulting in a more stable flow and less energy consumption. Besides, the structure and unit number of the Tesla-like channel has a great influence on the interaction with ultrasound waves. The simulated and experimental strategies could be used to improve the efficiency of ultrasound energy converted to flow motions. Furthermore, integrating miniaturized power sources, signal generator, and imaging apparatus would significantly enhance viscometer portability and practicality, such as enabling the quantification of plasma coagulation under fluid flow. Leveraging the integrated viscometer system could promote the point-of-care applications in clinic.
Methods
Fabrication of Tesla-like channel. This channel was fabricated by using maskless UV lithography (TuoTuo Technology, China) with 40 μm of layer resolution. The photocurable resin (HTL RESIN) was the functional acrylate, photo-initiator, and crosslinker, which was crosslinkable under the exposure of 405 nm light. The whole Tesla valve conduit was set as 3.5 cm 1 cm 0.2 cm. The length from position A to B in Tesla-like channel was 1.8 cm. There were one inlet and one outlet for introducing liquids. The channel was designed by Cinema 4D software and exported as stereolithography (STL) file. The channel file then was loaded into 3D printer (TTT-07-UV Litho-ACA) with 40 μm of layer resolution.
Activation of the Tesla valves and ultrasound waves-powered blood plasma viscometer. This viscometer was driven by sine radio frequency (RF) signals (working frequency, 2.06 MHz; power, 0–12.5 w) to achieve the stable flow pumping. The electric signals were controlled by a function generator (DG1022, RIGOL, China) and a power amplifier (LZY-22+, Mini-circuit, United States). By the electric stimulus, the piezoelectric transducer (PZT, Shenlei Ultrasonics, China) can generate ultrasound waves and propagated through the glass slice, and eventually interacted with the structures inside Tesla-like channel. Th high-frequency pulsatile flows can be generated in the conduit. With the regulation of the Tesla-like channel, pulsatile flows can be converted into unidirectional flows that towards the forward direction.
Simulation of the ultrasonic-powered pumping behavior. The pumping behavior was simulated via the finite element analysis (COMSOL 6.0, COMSOL Inc., Burlington, MA United States). The details can be found in the Supplementary Methods.
Preparation of Glycerol solutions. Five standard glycerol (G5516, Sigma Aldrich) solutions with viscosities at 0.95 cp, 1.90 cp, 3.80 cp, 7.60 cp, and 15.2 cp were prepared for calibrating the viscometer. Their concentrations were 0, 24, 40.2, 54.5, 62.5 % wt. All the solutions were prepared and used under the room temperature.
Preparation of blood plasma samples for viscosity measurements. Human blood plasma was obtained from Nanjing Drum Tower Hospital. All the experiments were conducted following the clinical guidelines of the Medical Clinical Research Ethics Review Form of Nanjing Drum Tower Hospital. This study was approved by the Institutional Review Board (IRB) of Nanjing Drum Tower Hospital (2022-481), Nanjing, China. Briefly, the plasma samples were used at the same time on repeated testing via commercial fully automatic hemorrheometer (Precil, ZL9 100C, China) and our viscometer. The volumes of plasma samples used in the commercial machine and our viscometer were 5 mL and 0.2 mL, respectively. Notably, Na salt at 4 mmol/L blood plasma was used as the anticoagulant, ensuring the minimal change in the plasma viscosity. All the samples were tested at the room temperature.
Ethics approval and consent to participate. This study was carried out using the blood samples and their information of 13 patients from our hospital. This study was approved by the Institutional Review Board (IRB) of Nanjing Drum Tower Hospital (approval no. 2022-481), Nanjing, China. Participants provided written informed consent prior to taking part in the study.
Characterizations. Movies were recorded by using an IX83 microscope (Olympus, Japan) with a CCD camera (DP72, Olympus, Japan). The imaging interval time of the CCD we used was 30 ms. Optical photos were obtained from a Leica stereomicroscope (M205FA, Germany). High-resolution images were acquired from a scanning electron microscope (JSM-IT200, Japan). The streakline visualization was performed in software ImageJ (Wayne Rasband, NIH). The viscosity of glycerol solutions was plotted and fitted using GraphPad Prism 10. We characterized the status of blood coagulation utilizing hydrodynamic principles, establishing a criterion whereby flow rates below 5 μL/h indicate a significant coagulation event. This decrease in flow rate is attributed to the obstruction of the microfluidic channel by coagulated blood samples. Moreover, the influence of acoustic waves on the process of blood coagulation was standardized across all experiments through the use of a consistent acoustic signal. Consequently, this standardization allows for the exclusion of ultrasound effects from the final comparative analysis of the coagulation outcomes.
Statistical analysis. The data of two comparing groups were analyzed by using the two-tailed t-test in GraphPad Prism 10. The statistical significance was denoted as: .
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.
Ethics statement
This study was carried out using the blood samples and their information of 13 patients from our hospital. This study was approved by the Institutional Review Board (IRB) of Nanjing Drum Tower Hospital (approval no. 2022-481), Naniing, China. Participants provided written informed consent prior to taking part in the study.
Author contributions
WC: Writing–original draft, Writing–review and editing. MX: Data curation, Supervision, Writing–review and editing. WZ: Software, Writing–review and editing. ZX: Methodology, Writing–review and editing. BC: Project administration, Writing–review and editing. HS: Funding acquisition, Resources, Writing–review and editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by the Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022-LCYJ-MS-28); Jiangsu Provincial Key Research and Development Program (BE2023721); Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022-LCYJ-PY-20); National Key Research and Development Program of China (SQ2023YFC2400135); Natural Science Foundation of China (61904057).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2024.1394373/full#supplementary-material
References
1
Al-kuraishyH. M.Al-GareebA. I.Al-HamashS. M.CavaluS.El-BousearyM. M.SonbolF. I.et al (2022). Changes in the blood viscosity in patients with SARS-CoV-2 infection. Front. Med.9, 876017. 10.3389/fmed.2022.876017
2
AoZ.WuZ.CaiH.HuL.LiX.KaurichC.et al (2022). Rapid profiling of tumor-immune interaction using acoustically assembled patient-derived cell clusters. Adv. Sci.9 (22), 2201478. 10.1002/advs.202201478
3
BhattadA. (2023). Review on viscosity measurement: devices, methods and models. J. Therm. Analysis Calorim.148 (14), 6527–6543. 10.1007/s10973-023-12214-0
4
BodnárT.SequeiraA.ProsiM. (2011). On the shear-thinning and viscoelastic effects of blood flow under various flow rates. Appl. Math. Comput.217 (11), 5055–5067. 10.1016/j.amc.2010.07.054
5
BohmS.PhiH. B.MoriyamaA.RungeE.StrehleS.KönigJ.et al (2022). Highly efficient passive Tesla valves for microfluidic applications. Microsystems Nanoeng.8 (1), 97. 10.1038/s41378-022-00437-4
6
CaiH.AoZ.WuZ.NunezA.JiangL.CarpenterR. L.et al (2020). Profiling cell-matrix adhesion using digitalized acoustic streaming. Anal. Chem.92 (2), 2283–2290. 10.1021/acs.analchem.9b05065
7
CarrollR. C.CraftR. M.LangdonR. J.ClantonC. R.SniderC. C.WellonsD. D.et al (2009). Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl. Res.154 (1), 34–39. 10.1016/j.trsl.2009.04.001
8
ChenL.LiD.LiuX.XieY.ShanJ.HuangH.et al (2022). Point-of-Care blood coagulation assay based on dynamic monitoring of blood viscosity using droplet microfluidics. ACS Sensors7 (8), 2170–2177. 10.1021/acssensors.1c02360
9
ChenL.YuL.ChenM.LiuY.XuH.WangF.et al (2023). A microfluidic hemostatic diagnostics platform: harnessing coagulation-induced adaptive-bubble behavioral perception. Cell Rep. Med.4 (11), 101252. 10.1016/j.xcrm.2023.101252
10
CollinsD. J.KhooB. L.MaZ.WinklerA.WeserR.SchmidtH.et al (2017). Selective particle and cell capture in a continuous flow using micro-vortex acoustic streaming. Lab a Chip17 (10), 1769–1777. 10.1039/c7lc00215g
11
CollinsD. J.MaZ.AiY. (2016). Highly localized acoustic streaming and size-selective submicrometer particle concentration using high frequency microscale focused acoustic fields. Anal. Chem.88 (10), 5513–5522. 10.1021/acs.analchem.6b01069
12
ConnesP.PichonA.Hardy-DessourcesM.WaltzX.LamarreY.SimmondsM. J. (2012). Blood viscosity and hemodynamics during exerise. Clin. Hemorheol. Microcirc.52, 101–109. 10.3233/CH-2011-1515
13
DavisJ. J.PadalinoM.KaplitzA. S.MurrayG.FosterS. W.MaturanoJ.et al (2021). Utility of low-cost, miniaturized peristaltic and Venturi pumps in droplet microfluidics. Anal. Chim. Acta1151, 338230. 10.1016/j.aca.2021.338230
14
Del Campo FonsecaA.GlückC.DrouxJ.FerryY.FreiC.WegenerS.et al (2023). Ultrasound trapping and navigation of microrobots in the mouse brain vasculature. Nat. Commun.14 (1), 5889. 10.1038/s41467-023-41557-3
15
De LeonardisF.ColalilloG.Finazzi AgròE.MianoR.FuschiA.AsimakopoulosA. D. (2022). Endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines10 (8), 1848. 10.3390/biomedicines10081848
16
DentryM. B.FriendJ. R.YeoL. Y. (2014). Continuous flow actuation between external reservoirs in small-scale devices driven by surface acoustic waves. Lab a Chip14 (4), 750–758. 10.1039/c3lc50933h
17
DingX.LiP.LinS. C.StrattonZ. S.NamaN.GuoF.et al (2013). Surface acoustic wave microfluidics. Lab a Chip13 (18), 3626–3649. 10.1039/c3lc50361e
18
DuX. Y.SwanwickM. E.FuY. Q.LuoJ. K.FlewittA. J.LeeD. S.et al (2009). Surface acoustic wave induced streaming and pumping in 128° Y-cut LiNbO3for microfluidic applications. J. Micromechanics Microengineering19 (3), 035016. 10.1088/0960-1317/19/3/035016
19
DurrerJ.AgrawalP.OzgulA.NeuhaussS. C. F.NamaN.AhmedD. (2022). A robot-assisted acoustofluidic end effector. Nat. Commun.13 (1), 6370. 10.1038/s41467-022-34167-y
20
El-SayedM. S.AliN.AliZ. E. (2005). Haemorheology in exercise and training. Sports Med.35 (8), 649–670. 10.2165/00007256-200535080-00001
21
FerroJ. M.CanhãoP.StamJ.BousserM.-G.BarinagarrementeriaF. (2004). Prognosis of cerebral vein and dural sinus thrombosis. Stroke35 (3), 664–670. 10.1161/01.str.0000117571.76197.26
22
FoleyJ. H.PetersenK.-U.ReaC. J.HarpellL.PowellS.LillicrapD.et al (2012). Solulin increases clot stability in whole blood from humans and dogs with hemophilia. Blood119 (15), 3622–3628. 10.1182/blood-2011-11-392308
23
FuianoF.ScorzaA.SciutoS. A. (2022). Functional and metrological issues in arterial simulators for biomedical testing applications: a review. Metrology2 (3), 360–386. 10.3390/metrology2030022
24
GanterM. T.HoferC. K. (2008). Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth. Analgesia106 (5), 1366–1375. 10.1213/ane.0b013e318168b367
25
GroismanA.QuakeS. R. (2004). A microfluidic rectifier: anisotropic flow resistance at low Reynolds numbers. Phys. Rev. Lett.92 (9), 094501. 10.1103/physrevlett.92.094501
26
GuoF.LiP.FrenchJ. B.MaoZ.ZhaoH.LiS.et al (2015a). Controlling cell-cell interactions using surface acoustic waves. P Natl. Acad. Sci. U. S. A.112 (1), 43–48. 10.1073/pnas.1422068112
27
GuoF.XieY.LiS.LataJ.RenL.MaoZ.et al (2015b). Reusable acoustic tweezers for disposable devices. Lab a Chip15 (24), 4517–4523. 10.1039/c5lc01049g
28
GuoF.ZhouW.LiP.MaoZ.YennawarN. H.FrenchJ. B.et al (2015c). Precise manipulation and patterning of protein crystals for macromolecular crystallography using surface acoustic waves. Small11 (23), 2733–2737. 10.1002/smll.201403262
29
HongC. C.ChoiJ. W.AhnC. H. (2004). A novel in-plane passive microfluidic mixer with modified Tesla structures. Lab a Chip4 (2), 109–113. 10.1039/b305892a
30
HossainS.AnsariM. A.HusainA.KimK. Y. (2010). Analysis and optimization of a micromixer with a modified Tesla structure. Chem. Eng. J.158 (2), 305–314. 10.1016/j.cej.2010.02.002
31
HuX.ZhaoS.LuoZ.ZuoY.WangF.ZhuJ.et al (2020). On-chip hydrogel arrays individually encapsulating acoustic formed multicellular aggregates for high throughput drug testing. Lab a Chip20 (12), 2228–2236. 10.1039/d0lc00255k
32
HuangP.-H.NamaN.MaoZ.LiP.RufoJ.ChenY.et al (2014). A reliable and programmable acoustofluidic pump powered by oscillating sharp-edge structures. Lab a Chip14 (22), 4319–4323. 10.1039/c4lc00806e
33
JainA.GravelineA.WaterhouseA.VernetA.FlaumenhaftR.IngberD. E. (2016). A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function. Nat. Commun.7 (1), 10176. 10.1038/ncomms10176
34
JędrzejczakK.MakowskiŁ.OrciuchW.WojtasK.KozłowskiM. (2023). Hemolysis of red blood cells in blood vessels modeled via computational fluid dynamics. Int. J. Numer. Methods Biomed. Eng.39 (11), e3699. 10.1002/cnm.3699
35
KangH.JangI.SongS.BaeS.-C. (2019). Development of a paper-based viscometer for blood plasma using colorimetric analysis. Anal. Chem.91 (7), 4868–4875. 10.1021/acs.analchem.9b00624
36
LeachA. M.WheelerA. R.ZareR. N. (2003). Flow injection analysis in a microfluidic format. Anal. Chem.75 (4), 967–972. 10.1021/ac026112l
37
LiW.YangS.ChenY.LiC.WangZ. (2023). Tesla valves and capillary structures-activated thermal regulator. Nat. Commun.14 (1), 3996. 10.1038/s41467-023-39289-5
38
MandalP. K. (2005). An unsteady analysis of non-Newtonian blood flow through tapered arteries with a stenosis. Int. J. Non-Linear Mech.40 (1), 151–164. 10.1016/j.ijnonlinmec.2004.07.007
39
MunozS. J.StravitzR. T.GabrielD. A. (2009). Coagulopathy of acute liver failure. Clin. Liver Dis.13 (1), 95–107. 10.1016/j.cld.2008.10.001
40
NguyenQ. M.AbouezziJ.RistrophL. (2021). Early turbulence and pulsatile flows enhance diodicity of Tesla’s macrofluidic valve. Nat. Commun.12 (1), 2884. 10.1038/s41467-021-23009-y
41
PrusaV. (2008). On the influence of boundary condition on stability of Hagen—Poiseuille flow. Computers&Mathematics Appl.57 (5), 763–771. 10.1016/j.camwa.2008.09.043
42
RubioA.LópezM.RodriguesT.Campo-DeañoL.VegaE. J. (2022). A particulate blood analogue based on artificial viscoelastic blood plasma and RBC-like microparticles at a concentration matching the human haematocrit. Soft Matter18 (39), 7510–7523. 10.1039/d2sm00947a
43
SahaB.MathurT.TronoloneJ. J.ChokshiM.LokhandeG. K.SelahiA.et al (2021). Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer. Sci. Adv.7 (30), eabg5283. 10.1126/sciadv.abg5283
44
TingL. H.FeghhiS.TapariaN.SmithA. O.KarchinA.LimE.et al (2019). Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk. Nat. Commun.10 (1), 1204. 10.1038/s41467-019-09150-9
45
TyagiT.JainK.GuS. X.QiuM.GuV. W.MelchingerH.et al (2022). A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. Nat. Cardiovasc. Res.1 (3), 223–237. 10.1038/s44161-022-00021-z
46
ValeanuL.GinghinaC.Bubenek-TurconiS. (2021). Blood rheology alterations in patients with cardiovascular diseases. Romanian J. Anaesth. Intensive Care28 (2), 41–46. 10.2478/rjaic-2021-0007
47
WangJ.CuiB.LiuH.ChenX.LiY.WangR.et al (2022). Tesla valve-based flexible microhybrid chip with unidirectional flow properties. ACS Omega7 (36), 31744–31755. 10.1021/acsomega.2c02075
48
WenF.LiuY.WangH. (2022). Clinical evaluation tool for vascular health– endothelial function and cardiovascular disease management. Cells11, 3363. 10.3390/cells11213363
49
WuZ.AoZ.CaiH.LiX.ChenB.TuH.et al (2023a). Acoustofluidic assembly of primary tumor-derived organotypic cell clusters for rapid evaluation of cancer immunotherapy. J. Nanobiotechnology21 (1), 40. 10.1186/s12951-023-01786-6
50
WuZ.CaiH.AoZ.NunezA.LiuH.BondessonM.et al (2019). A digital acoustofluidic pump powered by localized fluid-substrate interactions. Anal. Chem.91 (11), 7097–7103. 10.1021/acs.analchem.9b00069
51
WuZ.PanM.WangJ.WenB.LuL.RenH. (2022). Acoustofluidics for cell patterning and tissue engineering. Eng. Regen.3 (4), 397–406. 10.1016/j.engreg.2022.08.005
52
WuZ.SunL.ChenH.ZhaoY.RuanQ.HuangC.et al (2023b). Nanostructured conductive polypyrrole for antibacterial components in flexible wearable devices. Research6, 0074. 10.34133/research.0074
53
XieJ.ShihJ.LinQ.YangB.TaiY.-C. (2004). Surface micromachined electrostatically actuated micro peristaltic pump. Lab a Chip4 (5), 495–501. 10.1039/b403906h
54
XuJ.CaiH.WuZ.LiX.TianC.AoZ.et al (2023). Acoustic metamaterials-driven transdermal drug delivery for rapid and on-demand management of acute disease. Nat. Commun.14 (1), 869. 10.1038/s41467-023-36581-2
55
YiH.YangZ.JohnsonM.BramlageL.LudwigB. (2022). Hemodynamic characteristics in a cerebral aneurysm model using non-Newtonian blood analogues. Phys. Fluids34 (10), 103101. 10.1063/5.0118097
56
ZhangT.YuS.WangB.XuY.ShiX.ZhaoW.et al (2022a). A high spatiotemporal iontronic single-cell viscometer. Research2022, 9859101. 10.34133/2022/9859101
57
ZhangY. S.DavoudiF.WalchP.ManbachiA.LuoX.Dell’ErbaV.et al (2016). Bioprinted thrombosis-on-a-chip. Lab a Chip16 (21), 4097–4105. 10.1039/c6lc00380j
58
ZhangZ.SukhovA.HartingJ.MalgarettiP.AhmedD. (2022b). Rolling microswarms along acoustic virtual walls. Nat. Commun.13 (1), 7347. 10.1038/s41467-022-35078-8
Summary
Keywords
biofabrication, tesla valves, ultrasound wave, viscosity measurement, coagulopathy
Citation
Chen W, Xia M, Zhu W, Xu Z, Cai B and Shen H (2024) A bio-fabricated tesla valves and ultrasound waves-powered blood plasma viscometer. Front. Bioeng. Biotechnol. 12:1394373. doi: 10.3389/fbioe.2024.1394373
Received
01 March 2024
Accepted
11 April 2024
Published
24 April 2024
Volume
12 - 2024
Edited by
Kaushik Chatterjee, Indian Institute of Science (IISc), India
Reviewed by
Junhua Xu, West China Hospital, Sichuan University, China
Peng Li, West Virginia University, United States
Updates
Copyright
© 2024 Chen, Xia, Zhu, Xu, Cai and Shen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhiye Xu, xuzhiye@sina.com; Bo Cai, bcai@jhun.edu.cn; Han Shen, shenhan@njglyy.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.